U.S. Construction Stock News

NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Duolingo (DUOL) Stock May Be 50% Undervalued As Revenue Outlook Softens

Duolingo stock has had a tough year, with a sharp share price decline sitting alongside mixed valuation signals where the Discounted Cash Flow (DCF) intrinsic value estimate points to upside while traditional market multiples suggest the shares are expensive. Recent news around strong user growth but a softer revenue outlook has sharpened that debate about what the current price really builds in. Over the past 12 months Duolingo has fallen 58.9%, which means the market has already reset...
NYSE:FN
NYSE:FNElectronic

Fabrinet (FN) Heads To Rosenblatt AI Summit As Fair Value Debate Builds

Fabrinet (FN) shares are drawing attention after the company announced that its management will speak at the Rosenblatt 6th Annual Age of AI Technology Summit on August 18, 2026, in a live fireside chat webcast. See our latest analysis for Fabrinet. The Rosenblatt AI Summit appearance comes after a sharp rebound in Fabrinet’s share price, with a 1-month share price return of 20.49% and year-to-date share price return of 19.29%. This follows a 90-day period where the share price declined...
NYSE:CHH
NYSE:CHHHospitality

Why Choice Hotels (CHH) Is Down 5.6% After Cutting 2026 Profit Outlook Amid Tech Investments

In August 2026, Choice Hotels International reported softer quarterly earnings and lowered its full-year 2026 net income and EPS guidance, even as it continued Cambria’s upscale expansion with new hotels in Texas and Oregon and advanced an asset-light franchising strategy backed by a universal shelf registration and ongoing share repurchases. At the same time, management’s emphasis on improved net rooms growth, higher expected adjusted EBITDA and RevPAR, and increased investment in...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Saia (SAIA) Posts Strong Earnings And Awards, Is The 17% Undervaluation Convincing?

Saia earnings jump and industry awards put recent share moves in context Saia (SAIA) reported second quarter 2026 results with sales of US$956.49 million and net income of US$94.26 million, alongside two new Quest for Quality Awards that speak to its position in less than truckload freight. See our latest analysis for Saia. Saia's recent earnings and service awards come after a mixed price pattern, with the share price up 8.15% year to date but down 20.60% over 90 days. The 1 year total...
NYSE:FLOC
NYSE:FLOCEnergy Services

Flowco Holdings (FLOC) Could Be 25% Undervalued Following Earnings And Special Dividend

Why Flowco Holdings earnings and dividends matter now Flowco Holdings (FLOC) just released second quarter 2026 results, reporting revenue of US$235.86 million and net income of US$12.52 million, alongside a one time US$0.14 special dividend for shareholders. See our latest analysis for Flowco Holdings. Flowco Holdings shares trade at US$23.54 after a 7 day share price return of 13.61% and a 30 day share price return of 12.69%. However, the 90 day share price return declined 12.46%, while the...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

Applied Optoelectronics (AAOI) Reported Q2 Results And New Guidance, Is The Valuation Too Rich?

Applied Optoelectronics (AAOI) drew fresh attention after reporting second quarter 2026 results, with sales of $191.92 million and a net loss of $22.78 million, alongside new third quarter revenue guidance. See our latest analysis for Applied Optoelectronics. Applied Optoelectronics’ recent earnings release and new third quarter guidance came after a sharp rebound in the stock, with a 23.42% 1 month share price return and very large 1 year and multi year total shareholder returns following a...
NYSE:BKD
NYSE:BKDHealthcare

Why Brookdale Senior Living (BKD) Is Down 10.0% After Swinging To Q2 Profit On Lower Revenue

Brookdale Senior Living Inc. reported second-quarter 2026 results showing revenue of US$718.58 million, down from US$812.94 million a year earlier, but moved from a net loss of US$43.02 million to net income of US$23.27 million, with basic and diluted earnings per share from continuing operations improving from a loss of US$0.18 to earnings of US$0.10. Despite weaker top-line performance over both the quarter and first half, Brookdale returned to profitability, strengthened its balance sheet...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott International (MAR) Is Back In Focus, What Is Catching Attention?

Why Marriott International stock is back in focus Marriott International (MAR) is drawing fresh attention after reporting second quarter results that included global RevPAR growth of 3.4% and record development signings, alongside an increase in full year 2026 RevPAR guidance. Management also highlighted new long term U.S. co branded credit card agreements with JPMorgan Chase and American Express, which are expected to create additional value for loyalty members and hotel owners and help...
NYSE:PNW
NYSE:PNWElectric Utilities

Pinnacle West Capital (PNW) Confirms 2026 Guidance, Is It Still Undervalued?

Pinnacle West Capital (PNW) is back in focus after its August special call, which followed second quarter results, confirmed 2026 earnings guidance and a filed at-the-market equity offering of up to $500 million. See our latest analysis for Pinnacle West Capital. Pinnacle West Capital’s share price has eased over the past month, with a 30 day share price return of down 7.6%, even though the year to date share price return is 13.9% and the 5 year total shareholder return is 55.8%. This...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

Frontier Group Holdings (ULCC) Is Down 15.8% After Revenue Jumps But Net Loss Widens

In the past quarter, Frontier Group Holdings reported second quarter 2026 revenue of US$1,279 million, up from US$929 million a year earlier, alongside a wider net loss of US$90 million versus US$70 million previously. The combination of strong top-line growth and deeper losses highlights how cost pressures or operational issues are offsetting Frontier’s growing passenger revenue base. Next, we’ll examine how Frontier’s higher revenue but expanding net loss shapes its existing investment...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Amazon Stock Leads 3 US Retail Picks As Cooling Inflation Eases Pressure

Cooling US inflation, a more cautious Federal Reserve stance and relief on tariffs are quietly reshaping the outlook for value focused consumer and discount retailers. This mix of softer price pressures and potential margin relief could change how investors think about steady, cash generating US retailers exposed to these trends. This article walks through three stocks from our screener that appear positively exposed to this news backdrop and explains what investors should watch. The three...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer (PFE) Could Be 10% Undervalued Following Raised Revenue Guidance

Pfizer (PFE) is back in focus after its second quarter results came in ahead of internal expectations, prompting the company to lift full year revenue guidance and spotlight progress in key non COVID therapies. See our latest analysis for Pfizer. Pfizer's recent earnings beat, higher full year revenue guidance and progress in drugs like Eliquis and LITFULO have coincided with a 7.5% 30 day share price return and an 11.9% 1 year total shareholder return, although longer term total shareholder...
NYSE:CI
NYSE:CIHealthcare

Cigna Group (CI) Reports Fresh Earnings, Is The 19% Undervaluation Story Still Compelling?

Cigna Group (CI) is back in focus after its 30 July 2026 earnings release, which detailed second quarter and first half results, along with fresh context on buybacks, dividends and recent share performance. See our latest analysis for Cigna Group. Cigna Group's recent earnings and ongoing buybacks have come against a softer backdrop, with the share price at $277.41 and a 30 day share price return that has fallen 8.9%. However, the 5 year total shareholder return of 47.94% points to a steadier...
NYSE:THO
NYSE:THOAuto

How Prolonged Margin Pressure And Weaker Returns On Capital At THOR Industries (THO) Has Changed Its Investment Story

THOR Industries has faced several years of pressure, with annual sales falling around 2.3% and earnings per share dropping even faster, pointing to weaker profitability per unit sold. Returns on capital have also compressed, suggesting that the company’s earlier high-margin opportunities are harder to replicate and its existing profit engines are losing efficiency. Next, we will examine how these ongoing profitability challenges and weakening returns on capital influence THOR Industries’...
NYSE:MPT
NYSE:MPTHealth Care REITs

Medical Properties Trust (MPT) As Refinancing And Earnings Progress Feed The Undervalued View

Why Medical Properties Trust is back in focus after second quarter results Medical Properties Trust (MPT) is drawing fresh attention after its second quarter 2026 earnings, which showed a much smaller quarterly net loss and a return to net income for the first half. The company reported second quarter sales of US$236.71 million and revenue of US$259.28 million, with a net loss of US$2.6 million and basic loss per share from continuing operations of US$0.01. For the six months to June 30,...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

Why ADMA Biologics (ADMA) Is Up 5.6% After Reaffirming 2026 Revenue Guidance And EPS Momentum

ADMA Biologics recently reported its second-quarter 2026 results, with sales of US$124.4 million and net income of US$37.82 million, and it reaffirmed full-year revenue guidance of US$530 million to US$560 million. The combination of higher quarterly and year-to-date earnings per share versus last year and maintained revenue expectations highlights management’s confidence in the company’s current operating trajectory. Next, we’ll consider how ADMA’s reaffirmed 2026 revenue guidance could...
NYSE:CMI
NYSE:CMIMachinery

Cummins (CMI) Could Be 15% Undervalued Following Record Q2 Results And Higher Guidance

Cummins (CMI) just reported record second quarter sales and EBITDA, raised its full year 2026 revenue growth guidance to 10% to 13%, and outlined progress on its phased transition to new EPA emissions rules. See our latest analysis for Cummins. Despite Cummins lifting its 2026 revenue guidance after record quarterly results, the stock has eased in recent months, with a 30 day share price return of down 3.99% and a 90 day share price return of down 10.97%. Over a longer horizon, however,...
NYSE:GSL
NYSE:GSLShipping

Global Ship Lease (GSL) Has Investors Asking A Bigger Question

Global Ship Lease (GSL) is back in focus after confirming newbuild orders for 15 midsized, ultra high reefer container ships, all tied to multiyear charters that help reduce earnings and cash flow uncertainty. See our latest analysis for Global Ship Lease. At a share price of $41.24, Global Ship Lease has seen its 1 year total shareholder return reach 43.73%, while the 3 year total shareholder return sits at 160.77%. This suggests momentum has built over time, even as the 7 day share price...
NYSE:PINS
NYSE:PINSInteractive Media and Services

How Zillow Ad Data and AI Monetization Progress Could Shape Pinterest’s (PINS) Investment Narrative

Pinterest’s recent updates include Q2 2026 results showing revenue of US$1,179.65 million and a net loss of US$46.67 million, the appointment of Renee Jewell as Chief Accounting Officer effective August 26, 2026, and new Q3 2026 revenue guidance of US$1,190 million to US$1,210 million. In parallel, a new partnership with Zillow uses high-intent housing data to sharpen ad targeting on Pinterest, potentially deepening its role in commercial visual discovery across home-buying, renovation, and...
NasdaqGS:STEP
NasdaqGS:STEPCapital Markets

How Investors May Respond To StepStone Group (STEP) Earnings Miss, Dividend Hike and Private Wealth Buy-In

StepStone Group Inc. reported first-quarter 2026 results, with revenue rising to US$378.89 million from US$364.29 million a year earlier, while net loss widened to US$115.82 million and basic and diluted loss per share from continuing operations increased to US$1.41 from US$0.49. Alongside these results, StepStone raised its quarterly dividend to US$0.33 per share and outlined a buy-in of its Private Wealth profits interest, actions aimed at reshaping how it converts fundraising and platform...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

Why Copart (CPRT) Is Back In The Spotlight

Recent share performance and business context for Copart stock Copart (CPRT) has drawn attention after a mixed run in its share price, with the stock down over the past year and past 3 years, despite a gain over the past month. See our latest analysis for Copart. Recent price action suggests momentum in Copart is still under pressure, with the share price down over the past year despite a gain over the past month and a weaker total shareholder return over longer periods. If Copart’s moves...
NYSE:AGL
NYSE:AGLHealthcare

Agilon Health (AGL) Stock Still Looks Below Fair Value After Raised Guidance

agilon health has had an exceptionally strong run year to date, yet the stock still screens as undervalued on the broader checks, which raises a clear question about how much of the optimism is already in the price. Year to date, the share price is up about 412.2%, which puts recent volatility into sharp focus for anyone assessing what comes next. Recent membership growth and clinical initiatives can support expectations for future revenue, while any disappointment around how these programs...
NYSE:VNO
NYSE:VNOOffice REITs

Does Vornado Realty Trust (VNO) Change Its Manhattan Growth Case With 350 Park Avenue?

Vornado Realty Trust (NYSE:VNO) has entered a joint venture with Rudin Management and an affiliate of Kenneth Griffin for a new office project at 350 Park Avenue in Manhattan. The partnership plans a 1.9 million sq ft office development on Park Avenue, centered on a landmark property in Midtown. The deal formalizes Vornado's role alongside major partners and reflects a significant capital commitment to a high profile New York office asset. The project is expected to influence Vornado's long...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Taysha Gene Therapies (TSHA) Stock Trades At A Premium Despite A 232% Return

Taysha Gene Therapies stock has delivered a very strong 231.9% return over the past three years, yet current valuation checks and market multiples point to a less straightforward picture of whether the recent gains leave enough room for upside from here. The stock is up 231.9% over three years, which puts extra weight on whether recent optimism about its gene therapy pipeline is already reflected in the share price. Progress on TSHA-102 for Rett syndrome, including completed dosing in key...